Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft ...

Two recent decisions—one for Moderna and one against—are just the tip of the iceberg. Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week.

Wesfarmers Health managing director Emily Amos at the Atomica store in Castle Hill. She plans to roll out four Atomica stores in Melbourne by June 30. Peter Rae “The average price point is $20 ...

— La Moderna (@LaModerna_tve) March 7, 2025 Tas la Guerra Civil Don Fermín fue detenido y un tribunal popular lo juzgó por burgués, sin volver a saberse nada más de él.

La serie La Moderna termina este viernes (17.05) tras 18 meses en antena y más de 350 capítulos, y lo hace cuando contaba con mayor respaldo de la audiencia. Para sus responsables, este será un ...

Pfizer and BioNTech have convinced a U.S. Patent Office tribunal that two patents Moderna accused Pfizer-BioNtech of infringing were invalid. The companies have secured a victory in a round in their ...

Moderna has been hit by massive insider selling over the last couple of years. The stock has a 52-week high of over $170 while Moderna entered 2020 trading below $20, making insiders more likely ...

“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...

It wasn't all positive for Pfizer and BioNTech on the patent front this week, though. In Germany, the Düsseldorf Regional Court ruled for Moderna in a case that also dates back to 2022. The court ...

A German court has ruled that Pfizer and BioNTech violated Moderna's COVID-19 vaccine patent. The court in Duesseldorf stated that Pfizer and BioNTech must provide earning details and compensate ...

Pfizer Inc. and BioNTech SE convinced an administrative tribunal to throw out portions of two patents Moderna Inc. asserted against the companies in litigation over their competing Covid-19 vaccines.